Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 26 results

Search term: MF = 'C_{27}H_{35}ClN_{2}O_{7}'
12
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
49563

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C27H34N2O7.ClH/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32;/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32);1H/t17-,21-,22-;/m0./s1
C27H35ClN2O7535.029698400
20003512

Double-bond stereo

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C23H31ClN2O3.C4H4O4/c24-22-8-6-21(7-9-22)23(20-4-2-1-3-5-20)26-12-10-25(11-13-26)14-16-28-18-19-29-17-15-27;5-3(6)1-2-4(7)8/h1-9,23,27H,10-19H2;1-2H,(H,5,6)(H,7,8)/b;2-1-
C27H35ClN2O7535.029101300
22710761

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C27H35ClN2O7/c1-18(2)14-30(27(32)19-12-23(33-3)26(35-5)24(13-19)34-4)16-22-15-29(10-11-36-22)25(31)17-37-21-8-6-20(28)7-9-21/h6-9,12-13,18,22H,10-11,14-17H2,1-5H3
C27H35ClN2O7535.0297600
30798191

2 of 3 defined stereocentres - 2/3 defined
InChI=1/C27H34N2O7.ClH/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32;/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32);1H/t17-,21-,22?;/m0./s1
C27H35ClN2O7535.0297300
29766545

6 of 7 defined stereocentres - 6/7 defined
InChI=1/C25H33ClN2O3.C2H2O4/c1-16-6-7-21-19(22(29)30-25(21)20(16)8-9-24(2)23(25)31-24)15-27-10-12-28(13-11-27)18-5-3-4-17(26)14-18;3-1(4)2(5)6/h3-5,14,16,19-21,23H,6-13,15H2,1-2H3;(H,3,4)(H,5,6)/t16-,19?,20+,21+,23-,24-,25-;/m1./s1
C27H35ClN2O7535.0296500
5254075

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C27H34N2O7.ClH/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32;/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32);1H
C27H35ClN2O7535.0296800
5006893

Double-bond stereo

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C23H31ClN2O3.C4H4O4/c24-22-8-6-21(7-9-22)23(20-4-2-1-3-5-20)26-12-10-25(11-13-26)14-16-28-18-19-29-17-15-27;5-3(6)1-2-4(7)8/h1-9,23,27H,10-19H2;1-2H,(H,5,6)(H,7,8)/b;2-1+
C27H35ClN2O7535.0293300
262965

Double-bond stereo

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C23H31ClN2O3.C4H4O4/c24-22-8-6-21(7-9-22)23(20-4-2-1-3-5-20)26-12-10-25(11-13-26)14-16-28-18-19-29-17-15-27;5-3(6)1-2-4(7)8/h1-9,23,27H,10-19H2;1-2H,(H,5,6)(H,7,8)
C27H35ClN2O7535.0289999999992200
4941641

Double-bond stereo
InChI=1/C23H31ClN2O3.C4H4O4/c24-23-7-5-22(6-8-23)21-3-1-20(2-4-21)19-26-11-9-25(10-12-26)13-15-28-17-18-29-16-14-27;5-3(6)1-2-4(7)8/h1-8,27H,9-19H2;1-2H,(H,5,6)(H,7,8)/b;2-1-
C27H35ClN2O7535.0292200
76920458

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C27H34N2O7.ClH/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32;/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32);1H/t17-,21-,22+;/m0./s1
C27H35ClN2O7535.0292200
78315586

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C27H34N2O7.ClH/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32;/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32);1H/t17-,21+,22-;/m0./s1
C27H35ClN2O7535.0292200
99143365

Double-bond stereo
InChI=1/C27H35ClN2O7/c1-20-16-22(19-29-30-25(31)18-23-6-4-5-7-24(23)28)17-21(2)27(20)37-26(32)8-9-34-12-13-36-15-14-35-11-10-33-3/h4-7,16-17,19H,8-15,18H2,1-3H3,(H,30,31)/b29-19-
C27H35ClN2O7535.0291100
100528119

Double-bond stereo
InChI=1/C27H35ClN2O7/c1-19-5-6-23(24(28)15-19)27(32)30-29-18-22-16-20(2)26(21(3)17-22)37-25(31)7-8-34-11-12-36-14-13-35-10-9-33-4/h5-6,15-18H,7-14H2,1-4H3,(H,30,32)/b29-18-
C27H35ClN2O7535.0291100
110417521

Charge

Double-bond stereo
InChI=1/C27H30N2O3.ClO4/c1-6-28-23-14-16(3)21(12-17(23)4)26(19-10-8-9-11-20(19)27(31)32)22-13-18(5)24(29-7-2)15-25(22)30;2-1(3,4)5/h8-15,28-30H,3,6-7H2,1-2,4-5H3,(H,31,32);/q;-1/p+1/b26-21-;
C27H35ClN2O7535.0291200
112562298
InChI=1/C27H35ClN2O7/c1-6-35-23-13-18(14-24(36-7-2)25(23)37-8-3)27(32)30-11-9-17(10-12-30)26(31)29-20-16-21(33-4)19(28)15-22(20)34-5/h13-17H,6-12H2,1-5H3,(H,29,31)
C27H35ClN2O7535.0291100
129244839

1 of 2 defined stereocentres - 1/2 defined
InChI=1/C27H34N2O7.ClH/c1-18(2)23(28)24(30)34-19(3)35-26(32)29-16-14-22(15-17-29)36-25(31)27(33,20-10-6-4-7-11-20)21-12-8-5-9-13-21;/h4-13,18-19,22-23,33H,14-17,28H2,1-3H3;1H/t19?,23-;/m0./s1
C27H35ClN2O7535.0291100
71116821

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C27H34N2O7.ClH/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32;/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32);1H/t17-,21+,22+;/m0./s1
C27H35ClN2O7535.0291100
29787538

2 of 3 defined stereocentres - 2/3 defined
InChI=1/C27H34N2O7.ClH/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32;/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32);1H/t17-,21?,22+;/m0./s1
C27H35ClN2O7535.0291100
12

Advertisement